Cronos Q4 Sales Jump 27% On Higher Cannabis Flower And Extract Sales, Reports Improved Profitability - Cronos Group ( NASDAQ:CRON )
Cronos reported Q4 sales of $30.3M, missing estimates of $34.9M, but up from $23.9M last year, driven by strong cannabis sales. Adjusted EBITDA loss improved to $7.2M, while gross profit rose to $10.8M from $1.91M due to higher sales and cost improvements.
https://www.benzinga.com/news/earnings/25/02/44018198/cronos-q4-sales-jump-27-on-higher-cannabis-flower-and-extract-sales-reports-improved-profitability